Pay in 4 interest-free payments of $5.44 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Qualified researchers can review the full COA Library for complete batch-specific purity data
Our weight-loss research category includes Semaglutide, both Tirzepatide dosages, the other Retatrutide dosages, and AOD-9604 all COA-verified and GMP-sourced.
Semaglutide carries a boxed warning for risk of thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), and is contraindicated in patients with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
Seek immediate care for signs of serious allergic reactions including widespread rash, facial swelling, or difficulty breathing
Vibration during shipping can cause foaming, which sometimes appears as a haze on the surface
The Canadian Drug Agency assessed Wegovy's cost-effectiveness in July 2025 and recommended a price reduction, and December 2025 negotiations between the pan-Canadian Pharmaceutical Alliance and Novo Nordisk concluded without agreement
US$ 24.42
US$ 29.91
US$ 27.68
